Pulse Biosciences Inc (PLSE): Market Cap to Revenue

Symbol and logo of brand Pulse Biosciences Inc (PLSE)

Diversified component supply channels ensure high margins for Pulse Biosciences, Inc. (PLSE). The technological superiority of nanopulse systems and patent protection create significant barriers to entry for competitors. The P/S ratio history confirms the market valuation, where 2568.90 forms the current metric. Stable operation of the electroporation device assembly lines guarantees a steady increase in production volumes.

PLSE Pulse Biosciences Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Pulse Corp (PLSE)

- share price and consensus valuation forecast:
Price Performance Chart pulsebiosciences.com|PLSE - Price Target Chart
- stock exchange capitalization data:
Market Valuation Pulse Corp|PLSE - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Pulse Biosciences|PLSE - Book Capitalization|Capitalization to Book Value Ratio pulsebiosciences.com|PLSE - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Pulse Biosciences, Inc.|PLSE - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pulse Medical|PLSE - Company Aggregate Debts|Debts to Book Capitalization Pulse Corp|PLSE - Company Long-Term Debt|Company Short-Term Debt Pulse Biosciences|Intermediate Coverage Ratio pulsebiosciences.com
- earnings and multiples data:
PLSE - Net Profit|Expected Net Profit Pulse Biosciences, Inc.|PLSE - Price to Earnings Ratio|Forward Price to Earnings Multiple Pulse Biosciences Inc|PLSE - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Pulse Corp|PLSE - Operating profit EBITDA|Net earnings per share for the last four quarters Pulse Biosciences|PLSE - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months pulsebiosciences.com|PLSE - Earnings per share growth in current year|Expected earnings per share growth for next year Pulse Biosciences, Inc.
- issuer revenue and sales details:
PLSE - Revenue and Sales Volume|Company Expected Sales Volume pulsebiosciences.com|PLSE - Price-to-Revenue Ratio|Market Cap to Projected Revenue Pulse Corp
General company analysis:PLSE pulsebiosciences.com
Core merchandise of Pulse Biosciences, Inc.

Investors face a choice between overpaying for future growth and the risk of missing an asset during its expansion phase. By analyzing the price-to-sales ratio, you evaluate the market value per unit of sales, which is critical for Pulse Biosciences, Inc. (PLSE), as its diversification into cardiology and oncology reduces commercial risks and justifies specific multiples when bringing nanosecond technologies to market.

Competitors of Pulse Biosciences, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|INMD (InMode) - P/S Multiple|Picard Medical Corp (PMI) - Price-to-Revenue Coefficient|P/S Multiple SRDX|Market Cap to Revenue Eversense SENS|P/S Multiple NPCE (NeuroPace, Inc.)|P/S Multiple Tactile Systems Technology, Inc. TCMD|SNWV - Price-to-Revenue Ratio|OM: Price-to-Revenue Ratio|ELMD (smartvest.com) - Market Cap to Revenue|LENSAR Inc - Market Capitalization-to-Revenue Ratio|RCEL (AVITA Medical, Inc.) - P/S Multiple|Price to Sales Profound Medical Corporation PROF|Price-to-Revenue Ratio Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Price-to-Revenue Multiple|Apyx Medical Corporation - Market Cap to Revenue|P/S Multiple IceCure Medical Ltd. ICCM|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|Profusa Inc (PFSA) - Price-to-Revenue Ratio|Price-to-Sales Ratio SSKN (STRATA Skin Sciences, Inc.)|Market Cap to Revenue GCTK|P/S Multiple nanovibronix.com|Price-to-Revenue Ratio Venus Concept Corp (VERO)|Price-to-Revenue Ratio NUWE (Nuwellis Corp)|Price-to-Revenue Ratio Aethlon Medical AEMD|Price-to-Revenue Coefficient Asensus Surgical Inc (ASXC)|Avinger - P/S Multiple|Price to Sales BioSig|CUTR (Cutera, Inc) - Market Cap to Revenue|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|Price-to-Revenue Ratio NVRO|P/S Multiple RSLS|Price-to-Revenue Coefficient Silk Road Medical, Inc.